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ABSTRACT
Objective: The sodium/calcium exchanger (NCX) and the L-type Ca2+-channel (LTCC) are nowadays considered 
the major transmembrane transport mechanisms that control Ca2+ homeostasis. In pathophysiological conditions 
the altered function of these currents may infl uence the Ca2+ homeostasis and cardiac contractility and thereby, 
may enhance the development of severe tachyarrhythmias. The blockade of NCX current has been proposed as 
possible approach in the prevention and/or suppression of arrhythmias; however, this mechanism is not always 
favourable because the inhibition of both modes of NCX may induce Ca2+-overload. The decrease of the Ca2+ level 
by partial LTCC inhibition may be benefi cial in increasing the antiarrhythmic effi cacy. Therefore, the aim of our 
study was to investigate the antiarrhythmic effects of combined NCX and LTCC blockade in the ex vivo guinea pig 
arrhythmia model. 
Methods: We have performed Langendorff experiments in isolated guinea pig hearts. We have recorded 
electrocardiograms (ECG) and left ventricle pressure. We have applied 1 μM ORM-10962 (ORM), a compound 
that block NCX current and 30 nM nisoldipine for the inhibition of LTCC. Arrhythmias have been provoked by 
decreasing the activity of the sodium/potassium pump with 5 μM ouabain. 
Results: We found that neither LTCC nor NCX blockade alone increased, while the combined inhibition of the two 
currents signifi cantly delayed (p<0.05) the mean time of appearance of ouabain-induced ventricular fi brillation. 
The heart fr equency was affected by none of the drugs, only the left ventricular pressure (end-systolic and diastolic 
difference) was signifi cantly elevated by ORM (p<0.001).
Conclusion: In the Langendorff-perfused guinea pig heart, specifi c, combined NCX and LTCC blockade may be 
favourable than the inhibition of NCX or LTCC alone. However, further investigations are necessary to identify the 
pathological settings in which this combined cardiac drug therapy may be a potential new approach. 
Keywords: Langendorff-perfused hearts, guinea pig, NCX current, L-type calcium current, antiarrhythmic effect.
REZUMAT
Obiective. Transportorul de schimb sodiu/calciu (NCX) și curentul de calciu tip L (LTCC) sunt considerate 
actualmente drept principalele mecanisme de transport transmembranar ce controlează homeostazia calciului. 
În condiții patologice, alterarea funcțională a acestor curenți ionici poate interfera cu homeostazia calciului și 
contractilitatea cardiacă, cu posibilitatea apariției tahiaritmiilor severe. Blocarea schimbătorului NCX a fost propusă 
drept posibilă intervenție de prevenire sau supresie a acestor aritmii; cu toate acestea, acest mecanism poate fi  
nefavorabil deoarece blocarea ambelor moduri de funcționare ale curentului NCX poate induce supraîncărcarea 
de Ca2+. Reducerea nivelului de Ca2+ prin inhibiția parțială a curentului LTCC este considerată și ea drept un 
tratament antiaritmic efi cace. Ca atare, scopul studiului nostru a fost investigarea efectului de blocare combinată a 
canalului LTCC și a schimbătorului NCX pe un model de aritmii induse ex vivo la cobai. 
Metode: Inimile izolate de cobai au fost perfuzate retrograd tip Landendorff cu înregistrarea electrocardiogramei 
(ECG) și a presiunii în ventriculul stâng. În vederea inhibiției schimbătorului NCX a fost aplicat 1 μM ORM-10962 
(ORM) și, respectiv, pentru blocarea curentului LTCC a fost utilizată nisoldipina (30 nM). Aritmiile au fost induse prin 
reducerea activității pompei sodiu/potasiu (INa/K) cu ajutorul ouabainei (5 μM).
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Rezultate: Inhibarea combinată a LTCC și a NCX (dar nu și blocarea lor separată) a condus la o creștere semnifi cativă 
(p<0.05) a duratei medii de apariție a fi brilației ventriculare indusă prin blocarea pompei Na/K cu ouabaină. Compușii 
farmacologici nu au infl uențat frecvența cardiacă, dar presiunea ventriculară stângă (calculată ca diferența dintre cea 
telesistolică și diastolică) a crescut semnifi cativ dupa aplicarea compusului ORM (p<0.001). 
Concluzii: Pe modelul de inimă izolată de cobai, blocarea combinată a NCX și LTCC exercită un efect superior inhibiției 
separate a celor doi curenți ionici. Investigații suplimentare sunt necesare pentru a identifi ca condițiile patologice în care 
această terapie farmacologică combinată își va dovedi efi ciența terapeutică.
Cuvinte cheie: inimi perfuzate Langendorff, cobai, transportor de schimb NCX, curent de calciu tip L, effect antiaritmic.
INTRODUCTION
The cardiovascular diseases are life threatening patho-
logical conditions, which are best illustrated by EU 
statistics indicating that the ischaemic heart diseases 
were the main cause of death in Europe13,14. It is well-
known that prevalence of arrhythmias is extremely 
high in patients diagnosed with different heart diseases 
as acute myocardial infarction, congestive heart failure, 
etc, and we may state that typically in these patients 
the cardiac arrhythmias are the main cause of death. 
Unfortunately, the nowadays applied antiarrhythmic 
drugs, tools or other forms of treatment do not meet 
the expected therapeutical demand, thereby there is a 
high expectation in developing new and effi cient drugs 
for preventing or suppressing cardiac arrhythmias. 
The cardiac action potential is generated by the hi-
ghly organized and regulated function of a number of 
different transmembrane ion channels and electroge-
nic ion transport mechanisms. Among several other 
ion currents and transporters, the sodium/calcium 
exchanger (NCX) is considered as a crucial contribu-
tor to Ca2+ homeostasis in the myocardium4,5,24,25. The 
NCX is tightly regulated by the transmembrane Na+ 
and Ca2+ gradients and by the actual level of the mem-
brane potential. NCX can operate in a bidirectional 
fashion. In the forward mode NCX extrudes one Ca2+ 
from the cell which is coupled with three Na+ ions 
entering the cell. Thus, the forward mode generates 
inward current, which eventually depolarizes the cell 
membrane. The reverse mode of the NCX is activa-
ted when the cytoplasmic Na+ level is increased and 
the Ca2+ concentration is low and/or the membrane 
potential is depolarized. In this mode the NCX extru-
des three Na+ from the cell and moving one Ca2+ into 
the cell, and it can generate repolarizing net current. 
Under physiologic conditions, NCX operates mainly 
in forward mode and removes the same amount of 
Ca2+ that entered the cell through ICaL maintaining 
the beat-to-beat Ca2+ balance. At the same time, Ca2+ 
elimination leads to Na+ infl ux8. In the excitation-
contraction coupling (ECC), Ca2+ ions enter the cell 
from the extracellular space (Ca2+-infl ux) mainly via 
inward L-type calcium current (ICaL, LTCC). These 
channels are primarily present at sarcolemmal-sarco-
plasmatic reticulum (SR) junctions, in the vicinity of 
ryanodine receptors (RyRs). The Ca2+ infl ux increases 
the Ca2+ concentrations near the RyRs, which triggers 
Ca2+ release from the sarcoplasmic reticulum (SR). 
This mechanism is called “Ca2+-induced Ca2+ release” 
(CICR), which leads more Ca2+ to be released into 
the cytosol, resulting in a Ca2+ transient (CaT). In car-
diac muscle CaTs can be observed as a summary of 
spatio-temporally restricted Ca2+ sparks, which can be 
monitored by optical (fl uorometric) techniques. The 
free intracellular Ca2+ binds to the myofi laments and 
triggers contraction. After the contraction the relea-
sed [Ca2+]i is eliminated by both Ca2+ reuptake to the 
SRvia the activity of the SR Ca2+ pump (SERCA2a), and 
Ca2+ extrusion (effl ux) from the cell (primarily by the 
forward mode activity of the NCX)5-7. Sequestration 
of the released Ca2+ and stabilization of the diastolic 
[Ca2+]i between contractions is crucial in the regula-
tion of the beat-to-beat Ca2+ balance under varying 
conditions. The majority of the released Ca2+ is reup-
take by SERCA2a. A much smaller amount of [Ca2+]
i is extruded from the cell, primarily via the forward 
mode activity of the NCX. An ATP-dependent Ca2+ 
transporter, the Ca2+ pump of the plasma membrane 
(PMCA) may also extrude Ca2+, however, its contri-
bution to maintaining Ca2+ balance is much less impor-
tant, and its role is suggested to be primarily restricted 
to fi ne tuning of the diastolic Ca2+ level11. In steady 
state, during each cycle, the released and reuptake 
Ca2+, as well as the entered and extruded Ca2+ must 
be equal. 
Since the extrusion of one Ca2+ is coupled with 3 
Na+ entering the cell, during the forward mode of the 
NCX net inward current is carried which, when intra-
cellular Ca2+ is elevated, can cause substantial depolari-
zation leading to early (EAD) and delayed (DAD) after 
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2. Is or not a benefi cial therapeutic intervention for 
preventing/suppressing cardiac arrhythmias the 
partial per se NCX or combined NCX + LTCC 
blockade, respectively, in isolated (Langendorff 
perfused) guinea pig hearts?
METHODS
Animals
Langendorff perfused guinea hearts were used for 
ouabain induced arrhythmia studies. Adult guinea pigs 
of either sex weighing 300-500g obtained from a re-
cognised supplier were used for the study. All experi-
ments were conducted in compliance with the Guide 
for the Care and Use of Laboratory Animals (USA NIH 
publication No. 85-23, revised 1996) and conformed 
to Directive 2010/63/EU of the European Parliament. 
The protocols were approved by the Review Board of 
the Department of Animal Health and Food Control 
of the Ministry of Agriculture and Rural Development, 
Hungary (XIII./1211/2012). 
Isolated heart experiments
Guinea pigs of either sex weighing 300-500 g were 
used for these experiments, that we described ear-
lier15. Animals were anaesthetised with sodium-pen-
tobarbital (500 mg/kg, i.p.) and injected with heparin 
sodium (300 IU i.v.). Hearts were rapidly excised, 
mounted via the aorta on a Langendorff apparatus 
and perfused retrograde with warm (37°C), modifi ed 
Krebs–Henseleit bicarbonate (KHB) buffer at a con-
stant pressure (60 mmHg). The KHB solution contai-
ned (in mmol/l): NaHCO3 25; KCl 4.3; NaCl 118.5; 
MgSO4 1.2; KH2PO4 1.2; glucose 10; CaCl2 1.8, having 
a pH of 7.4±0.05 when gassed with carbogene (95% 
O2 + 5% CO2). The Langendorff perfused apparatus is 
a suitable technique for investigating drug effects and 
for modelling ischaemia-reperfusion injury diseased 
models. The main advantage of the model is that in 
isolated hearts ceases the regulation of the neurohu-
moral enervation, which makes enable the better in-
vestigation of the direct drug effects22.
Perfusion fl ow and the electrocardiogram (ECG) 
were simultaneously recorded using the WinWCP 
software (V4.9.1. Whole Cell Electrophysiology 
Analysis Program, John Dempster, University of 
Strathclyde, UK).
Arrhythmia diagnosis: For the induction of 
arrhythmia, we used ouabain (Sigma) and the drugs 
(ORM-10962, Nisoldipine) or solvent were adminis-
tered 10 minutes before starting ouabain perfusion. 
depolarizations. EAD and DAD is generally thought to 
play an important role in arrhythmogenesis16,26, especi-
ally under conditions where potassium conductance is 
decreased, such as heart failure21. In the past two de-
cades, several NCX inhibitors were developed having 
different potency and selectivity. The KB-R7943 mar-
kedly suppressed the NCX current however exerted 
poor selectivity9. The SEA-0400 (SEA) is a widely used, 
potent NCX inhibitor which considerably improved 
our knowledge about the NCX function however a ~ 
20% inhibition of ICaL made the data interpretation di-
ffi cult9. The ORM-1010317,23 and ORM-1096218 and 
GYKB-663515 are recently synthesised, novel NCX 
inhibitors having an appropriate selectivity profi le to 
investigate the NCX functionon the cardiac action po-
tential waveform and repolarization.
The blockade of NCX current has been proposed 
as possible approach in the prevention and/or suppre-
ssion of arrhythmias21, however this mechanism is not 
always favourable because the inhibition of both mo-
des of NCX may induce Ca2+-overload. The decrease 
of the Ca2+ level by partial LTCC inhibition may be 
benefi cial in the antiarrhythmic effi cacy. 
The combined NCX+LTCC blockade was fi rst time 
studied by Bourgonje et al. (2013) by investigating the 
combined effect of SEA-0400 + verapamil in a chronic 
AV block dog model. They concluded that the combi-
nation of the two drugs may be benefi cial by counter-
balancing the negative side effects of the monotherapy 
of the LTCC blockade, ie, unlike specifi c inhibition of 
LTCC, combined NCX and LTCC inhibition has no 
negative effects on cardiac hemodynamics. This study, 
however, has some weaknesses because either the se-
lectivity of SEA-0400 (blocks not only but also ICaL at 
the same concentration range), or verapamil (blocks 
repolarising K+ currents) is questionable. These ob-
servation makes questionable the results of the study 
of Bourgonje et al. (2013), because it is diffi cile to 
identify which compound (SEA or verapamil) was the 
main antiarrhythmic factor of the combined therapy.
Therefore, the aim of our study was to investi-
gate the antiarrhythmic effects of combined ORM-
10962+nisoldipine blockade in ex vivo guinea pig ar-
rhythmia model. The selectivity of ORM-10962 on 
NCX current18 and of nisoldipine on ICaL current19 
are well documented and confi rmed. We focused on 
two directions:
1. How the heart frequency and pump function is 
affected by partial perse NCX or by combined 
NCX + LTCC blockade, respectively?
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error of the mean (SEM) and the groups were compa-
red in pairs by means of the “t-test”. Statistically sig-
nifi cant differences are marked in fi gures by * p<0.05.
Chemicals
Except for the nisoldipine (gift from Bayer AG, Le-
verkusen, Germany) and ORM-10962 (gift from Orion 
Ventricular extra beat (VEB), bigeminia, salvo, ventri-
cular tachycardia (VT) and ventricular fi brillation (VF) 
were defi ned according to the Lambeth Conventions I 
and II, respectively27.
Statistics: All data from independent samples. 
Following data were expressed as mean ± standard 
Figure 1. The investigational protocol of the ouabain induced arrhythmia model in isolated guinea pig hearts. The bands represent the respective 
experimental groups: 1st row: control; 2nd row: test nisoldipine; 3rd row: test ORM-10962; 4th row: test ORM+nisoldipine. The demarcation lines rep-
resent the 3 distinct periods of the experiments: stabilization period, pre-treatment period and arrhythmia provocation period.
Figure 2. Heart rate values from isolated guinea pig hearts for control and tested drugs. The bars represent mean values before (white) and after 
(black) treatment ± SEM.
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with a KH solution which contained the drug solvent 
(1st group) or test drug (2nd-4th groups); iii) arrhythmia 
provocation period, we have superfused the hearts 
with 5 μM ouabain in the continuous presence of the 
compound form the second period (solvent or test 
drugs). The numbers of experiments in all groups 
were as follow: control – 5 hearts; nisoldipine - 5 
hearts, ORM -5 hearts; Niso+ORM – 6 hearts.
Statistics
All data are expressed as means ± SEM. Statistical 
analysis was performed with Student’s t-test for paired 
data. The results were considered statistically signifi -
cant when P was < 0.05. 
RESULTS
In each experimentwe examined changes in the para-
meters of left ventricular pressure and the arrhythmi-
as before and after ouabain (5 μmol/L) administration 
in isolated guinea-pig hearts. The heart rate was not 
signifi cantly affected by either agent, however, the 
change in left ventricular developed pressure (systole 
minus end-diastole pressure) was signifi cantly increa-
sed by ORM (p<0.001). Averaging the time to onset 
of ventricular fi brillation, we found that neither LTCC 
inhibition nor NCX inhibition had a signifi cant pro-
tective effect on hearts, whereas combined inhibition 
Pharma, Espoo, Finland) all chemicals were purchased 
from Sigma-Aldrich Fine Chemicals (St. Louis, MO, 
USA). ORM-10962, nisoldipine and ouabain were dis-
solved in DMSO to yield a 1mM stock solution, re-
spectively. These stock solutions were diluted to rea-
ch the desired fi nal concentration in the Langendorff 
apparatus.
Investigational protocols
On order to test the blocking effects of NCX and L-
type Ca2+-currents in mono and comb ined therapy by 
applying a ouabain induced arrhythmia model in isola-
ted guinea pig hearts, we applied the following expe-
rimental protocol (Figure 1). Our experiments were 
divided in four groups. 
The fi rst group was the time control. The second 
and third groups contained the animal which were 
tested with the effect of nisoldipine (30nM Niso, 2nd 
group) and ORM-10962 (1 μM ORM, 3. group) mo-
notherapy, respectively, while the last group of guinea 
pigs where, which we analysed the combined effects 
of the NCX and LTCC blockers (same amount of 
Niso+ORM).
Each set of experiments consisted of three distinct 
periods: i) stabilization period of 10 minutes of the 
isolated hearts with superfusion with KH solution; ii) 
preincubation period, then for another 10 minutes 
Figure 3. Investigation of changes in left ventricular pressures from isolated guinea pig hearts in the control state and after drug administration. Ven-
tricular pressure was calculated from the difference between end-systolic and end-diastolic pressures. ORM treatment showed a signifi cant difference 
compared to the control (p < 0.001). The bars represent mean values before (white) and after (black) treatment ± SEM.
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11.5 vs. 40.0 ± 15.6 Hgmm, ORM 45.6 ± 4.0 vs. 69.6 
± 4.3 Hgmm, ORM + Niso 35.2 ± 3.6 vs. 37.0 ± 7.2 
Hgmm).
Registered ECGs were analysed from the 20th mi-
nute of our experiments, and the arrhythmia map was 
made after the addition of 5μM Ouabain. We exami-
ned which types of arrhythmias develop / are present 
at a given minute (Figure 4). Each category was re-
presented by different colours: the arrhythmia-free 
time interval was marked in yellow, followed by ar-
rhythmias in different colours: ventricular extrasysto-
les (brown), bigeminias, salvos (blue), ventricular ta-
chycardia (green), and ventricular fi brillation (red). Va-
lues were plotted for 7 minutes (420 seconds) becau-
se thereafter, cardiac function no longer changed, and 
fi brillation stabilized in all cases. The ORM-1962 alone 
(ORM) and combined with Nisoldipine (ORM+Niso) 
signifi cantly delayed the number of arrhythmias and 
fi brillation episodes compared to control (Figure 4).
In the control group, the first arrhythmias, deve-
loped around the second minute. Several minutes la-
ter, ventricular tachycardia appeared, that followed 
signifi cantly delayed the onset of ventricular fi brillation 
compared to control (p<0.05).
Heart rate values were calculated from the minutes 
9 and 19 before and after drug administration (Figu-
re 2). The fi rst periods of our experiment (Normal) 
are the white bars, the treatments are the black bars. 
The ORM, nisoldipine and combination treatments did 
not cause a signifi cant difference compared to nor-
mal heart rate (control 256±19.5 vs. 240±24.5 1/min; 
Nisoldipine 265.7±17.4 vs. 238.3±15.4 1/min; ORM 
261.6±4.8 vs. 252±3.8 1/min; ORM+Niso 272±10.7 
vs. 256±6.4 1/min)
Developed left ventricular pressure values were 
measured using a latex balloon placed in the left ven-
tricle and the recorded data were analysed offl ine. The 
mean differences in systolic and diastolic end pressure 
values were calculated at 9 and 19 minutes before and 
after 10 minutes drug administration. Figure 3 shows 
that for ORM we found a signifi cant difference betwe-
en the stabilization period (before white bar) and the 
treatment period (after black bar) (p<0.001) (control 
36.0 ± 10.4 vs. 39.4 ± 10.8 Hgmm, Nisoldipine 47.5 ± 
Figure 4. The total arrhythmia map analysed from all hearts. The X axis shows the time after ouabain perfusion; Y axis: arrhythmia diagrams of 20 
individual hearts. The hearts were divided into 4 groups: Control; Nisoldipine 30nM, ORM-10962 1 μM and 1 μM ORM+ 30nM Nisoldipine.  Each 
of the horizontal lines represent a single heart. Time periods with the various arrhythmia stages are shown in colour: regular sinus rhythm (yellow); 
multiple extrasystoles (orange); bigeminy (blue): ventricular tachycardia (green): ventricular fi brillation (red).
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The ORM-induced pressure increasing effect is in 
accord with the pharmacological profi le of the com-
pound, however this effect disappeared when the 
drug was tested in combination with the LTCC in-
hibitor nisoldipine (Figure 3). Our data demonstrates 
that the additional application of a selective LTCC in-
hibitor may prevent and/or avoid the Ca2+-overload 
induced by the NCX blockade. One may speculate 
that this combination may be effi cacious to prevent 
Ca2+-overload induced arrhythmias, for example in is-
chaemia-reperfusion injuries. This speculation is stren-
gthened by a previous observation which reported 
that NCX blockade with ORM-10962 monotherapy 
could not prevent the I/R induced arrhythmias nei-
ther in coronary artery occlusion-reperfusion induced 
arrhythmias anesthetized rat model nor in zero fl ow 
ischaemia-reperfusion induced arrhythmias in guinea-
pig Langendorff hearts23,18. Neither ORM and Niso nor 
ORM+Niso combination affected the heart frequency. 
Our results indicate that 5 μM ouabain induced li-
fe-threatening arrhythmias in all investigated hearts. 
The preincubation with the combined ORM and Niso 
(NCX+LTCC) blockade signifi cantly decreased the in-
cidence rate of arrhythmias (Figure 4), and fi rst appea-
rance of ventricular fi brillation (Figure 5). This infor-
mation is in good agreement with the data reported by 
Kohajda et al. (2016), where ORM-10962 signifi cantly 
supressed the VT/VF in anaesthetized guinea pig mo-
by fibrillation around the fourth minute after starting 
ouabain administration. The time of the fi rst appea-
rance of ventricular fi brillation (Figure 5) was calcula-
ted from the beginning of ouabain administration and 
the elapsed time was expressed in seconds. A signifi -
cant difference was observed only for ORM + nisol-
dipine compared to the control (*p<0.05), which is 
marked with an asterisk. Nisoldipine and ORM-10962 
pre-treatment were no significantly effect, but ORM 
showed a tendency on First VF time.
DISCUSSION
Main fi ndings
The main fi nding of this study was: i) the sodium-cal-
cium exchanger (NCX) blocker ORM-10162 -accor-
ding with literature data- during preincubation period 
signifi cantly increased the left ventricular pressure, 
while the L-type calcium channel (LTCC) inhibitor ni-
soldipine neither alone nor in combination with ORM 
compound altered substantially the cardiac pump 
function; ii) ORM and Niso monotherapy (preincuba-
tion with ORM or Niso) did not prevent the ouabain 
induced cardiac arrhythmias, ie, did not delayed the 
time of appearance of VT/VF, while the combination 
of the drugs signifi cantly delayed it, ie. the combined 
NCX+LTCC blockade possess antiarrhythmic poten-
cy against triggered arrhythmias.
Figure 5. The fi rst appearance of VF in all groups after ouabain administration. The effi cacy of individual inhibitors and inhibitor combinations has 
been evaluated against the control hearts. The bars represent mean values ± SEM, after drug or vehiclepre-treatment and ouabain administration.
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draw the main conclusion that the combined blockade 
is effi cacious in preventing (by delay) or suppresing of 
ouabain induced (delayed afterdepolarization based) 
arrhythmias.
CONCLUSION
Our results indicated that the decrease of the 
Ca2+overload by combined NCX+LTCC blockade is 
more favourable than specifi c separate NCX or LTC 
inhibitions alone. 
Our results indicate that it would be worthwile to 
continue this direction and investigate the possible 
effect of combined NCX+LTCC blockers using better 
compounds as nisoldipine. Finally, we may also conclu-
de that this combination may be useful in heart failure 
or any other Ca2+-overload related cardiac diseases 
as ischaemia since the drug combination did not affect 
the pump function or the heart frequency, but may 
prevent any arrhythmias induced by altered Ca2+-ho-
meostasis.
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er K+-current
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del. Nisoldipine preincubation alone did not possess 
any protective effect against ouabain induced arrhyth-
mias. We may argue that the applied concentration 
(30 nM nisoldipine) is extremely low, but obviously 
we must state that we have opted for application of 
nisoldipine because it well-known as selective and po-
tent ICaL blockers, and not as typical antiarrhythmic 
agent. Finally, the results of the combined application 
of NCX+LTCC blockers support our hypothesis. 
The combined NCX+LTCC blockade was fi rst 
time studied by Bourgonje et al (2013) by investiga-
ting the combined effect of SEA0400+verapamil in 
a chronic AV-block dog model of arrhythmia. They 
reported that 1 μM SEA-0400 blocked by more than 
50% either forward or reverse modes of NCX and at 
least 33% the L-type calcium current. SEA compound 
did not affect left ventricular pressure and effectively 
decreased in a concentration dependent manner the 
development of the dofetilide induced Torsades de 
Pointes (TdP) arrhythmias. Verapamil exerted a nega-
tive inotropic effect, but also prevented the prevalen-
ce of TdPs. They concluded that the combination of 
the two drugs may be benefi cial by counterbalancing 
the negative side effects of the monotherapy of the 
LTCC blockade, ie, unlike specifi c inhibition of LTCC, 
combined NCX and LTCC inhibition has no negative 
effects on cardiac hemodynamics. This study, howe-
ver, has several weaknesses: i) the selectivity of SEA-
0400 is questionable, because at the concentration 
range where the compound effectively inhibits both 
NCX modes (»1 μM) it block also least 30-50% the 
amplitude of the ICaL current also (1); ii) the selecti-
vity of verapamil is also questionable, several studies 
reported that verapamil may also block repolarizing 
potassium currents for example IKr/HERG current20; 
2. These observation makes questionable the results 
of the study of Bourgonje et al. (2013), because it is di-
ffi cile to identify which compound (SEA or verapamil) 
was the main antiarrhythmic factor of the combined 
therapy.
Limitation of the study
We must emphasize two limitations:
First, nisoldipine was not the best option in this 
investigation because unfortunately possess strong 
coronary dilating and smooth muscle relaxing effects, 
which may diminish the potential antiarrhythmic effect 
of the combined drug effects. Second, the other limi-
tation of our investigation was the relative low num-
ber of experimenst in each study groups, however, 
the satistics were clear and conlusive, and we could 
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PMCA plasma membrane Ca2+-ATPase
RyR Ryanodin receptor 
SEA SEA-0400 substance
SERCA sarcoplasmic reticulum membrane 
Ca2+-ATPase
SR sarcoplasmic reticulum
TdP Torsades de Pointes arrhythmia
VT/VF ventricular tachycardia/fi brillation
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